Leishmaniae are obligatory intracellular protozoa in mononuclear phagocytes. They cause a
spectrum of diseases, ranging in severity from spontaneously healing skin lesions to fatal …

Currently there are no effective orally administered drugs or visceral leishmaniasis or kala-
azar, a parasitic disease affecting about 0.5 million people a year, majority of whom are in …

Patients with clinical manifestations of leishmaniasis, including cutaneous leishmaniasis,
have limited treatment options, and existing therapies frequently have significant untoward …

Leishmania parasites are responsible for a diverse collection of diseases of humans and
other animals. Cysteine proteases are putative virulence factors of leishmania parasites …

We investigated factors associated with treatment failure in the treatment of cutaneous
leishmaniasis with meglumine antimony in a reference service in Mato Grosso State. A …

A fast agglutination screening test (FAST) for the detection of anti-Leishmania antibodies in
serum samples from dogs with visceral leishmaniosis was developed. The test is based on …

Foram investigados os fatores associados ao insucesso do tratamento da leishmaniose
cutânea com antimoniato de meglumina num serviço de referência para leishmanioses, em …

Background: Leishmaniasis constitutes a variety of human diseases ranging in severity from
a spontaneously healing skin ulcer to an overwhelming visceral disease. Leishmaniasis …

Afghanistan currently has the world's largest outbreak of Cutaneous Leishmaniasis with
more than 9% of the population (270,000) of Kabul affected. Transmitted through the bite of …

Background. Increased expression of linkage-specific 9-O-acetylated sialoglycans (9-O-
AcSGs) has been demonstrated on erythrocytes from patients with visceral leishmaniasis …